19-Hydroxyeicosatetraenoic acid (19-HETE, 1), a metabolically and chemically labile cytochrome P450 eicosanoid, has diverse biological activities including antagonism of the vasoconstrictor 20-hydroxyeicosatetraenoic acid (20-HETE, 2). A SAR study was conducted to develop robust analogs of 1 with improved in vitro and in vivo efficacy. Analogs were screened in vitro for inhibition of 20-HETE-induced sensitization of rat renal preglomerular microvessels toward phenylephrine and demonstrated to normalize the blood pressure of male Cyp4a14(-/-) mice that display androgen-driven, 20-HETE-dependent hypertension
20-Hydroxyeicosatetraenoic acid (20-HETE) is a bioactive lipid generated from the ω-hydroxylation of...
We have shown previously that increased vascular endothelial expression of CYP4A2 leads to 20-hydrox...
20-Hydroxyeicosatetraenoic acid (20-HETE) production is increased in ischemic kidney tissue and may ...
Vascular function is dynamically regulated and dependent on a bevy of cell types and factors that wo...
OBJECTIVE: 20-Hydroxyeicosatetraenoic acid (20-HETE) is a vasoactive eicosanoid exhibiting effects o...
20-hydroxyecosatetraenoic acid (20-HETE) is a metabolite of arachidonic acid (AA) formed via CYP4 en...
Abstract—We compared renal interlobar arteries of spontaneously hypertensive rats (SHR) and Wistar-K...
20-HETE, the omega-hydroxylation product of arachidonic acid catalyzed by enzymes of the cytochrome ...
OBJECTIVE: 20-hydroxyeicosatetraenoic acid (20-HETE) is a potent constrictor in small arteries and a...
Background: 20-HETE and EETs, metabolites derived from arachidonic acid by cytochrome P-450 (CYP), a...
RATIONALE: 20-Hydroxyeicosatetraenoic acid (20-HETE), one of the principle cytochrome P450 eicosanoi...
19(S)-hydroxy-eicosatetraenoic acid (19(S)-HETE) belongs to a family of arachidonic acid metabolites...
20-hydroxyecosatetraenoic acid (20-HETE) and epoxyecosatetraenoic acids (EETs) are metabolites of ar...
20-hydroxyeicosatetraenoic acid (20-HETE) is a metabolite of arachidonic acid (AA) formed by cytochr...
19(S)-hydroxy-eicosatetraenoic acid (19(S)-HETE) belongs to a family of arachidonic acid metabolites...
20-Hydroxyeicosatetraenoic acid (20-HETE) is a bioactive lipid generated from the ω-hydroxylation of...
We have shown previously that increased vascular endothelial expression of CYP4A2 leads to 20-hydrox...
20-Hydroxyeicosatetraenoic acid (20-HETE) production is increased in ischemic kidney tissue and may ...
Vascular function is dynamically regulated and dependent on a bevy of cell types and factors that wo...
OBJECTIVE: 20-Hydroxyeicosatetraenoic acid (20-HETE) is a vasoactive eicosanoid exhibiting effects o...
20-hydroxyecosatetraenoic acid (20-HETE) is a metabolite of arachidonic acid (AA) formed via CYP4 en...
Abstract—We compared renal interlobar arteries of spontaneously hypertensive rats (SHR) and Wistar-K...
20-HETE, the omega-hydroxylation product of arachidonic acid catalyzed by enzymes of the cytochrome ...
OBJECTIVE: 20-hydroxyeicosatetraenoic acid (20-HETE) is a potent constrictor in small arteries and a...
Background: 20-HETE and EETs, metabolites derived from arachidonic acid by cytochrome P-450 (CYP), a...
RATIONALE: 20-Hydroxyeicosatetraenoic acid (20-HETE), one of the principle cytochrome P450 eicosanoi...
19(S)-hydroxy-eicosatetraenoic acid (19(S)-HETE) belongs to a family of arachidonic acid metabolites...
20-hydroxyecosatetraenoic acid (20-HETE) and epoxyecosatetraenoic acids (EETs) are metabolites of ar...
20-hydroxyeicosatetraenoic acid (20-HETE) is a metabolite of arachidonic acid (AA) formed by cytochr...
19(S)-hydroxy-eicosatetraenoic acid (19(S)-HETE) belongs to a family of arachidonic acid metabolites...
20-Hydroxyeicosatetraenoic acid (20-HETE) is a bioactive lipid generated from the ω-hydroxylation of...
We have shown previously that increased vascular endothelial expression of CYP4A2 leads to 20-hydrox...
20-Hydroxyeicosatetraenoic acid (20-HETE) production is increased in ischemic kidney tissue and may ...